Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase Inhibitors.

作者: Nivya James , V. Shanthi , K. Ramanathan

DOI: 10.1007/S12010-019-03156-1

关键词:

摘要: Targeting anaplastic lymphoma kinase (ALK) is one of the important treatment strategies for non-small cell lung cancer (NSCLC). In present perspective, multidimensional approaches were used identification ALK inhibitors. Initially, an e-pharmacophore model was generated using PHASE algorithm and as a 3D query to screen 468,200 molecules ASINEX database. Prior screening process, evaluated its significance ability differentiate actives from inactives, enrichment analysis. Subsequently, hierarchical docking protocol binding free energy calculations instigated GLIDE Prime module, respectively. Further, pharmacokinetic/pharmacodynamics (PK/PD) properties toxicities hit compounds envisaged respectively QikProp program, Osiris explorer, Protox-II algorithm. These retrieved two hits namely BAS 00137817 00680055 with acceptable absorption, distribution, metabolism, excretion toxicity (ADMET) higher affinity towards protein. Additionally, density functional theory molecular dynamics simulations performed validate inhibitory activity lead compounds. It noteworthy mention that all constitute particular scaffolds which play major role in downregulation some ALK-positive pathways. We speculate outcomes this research are substantial prominence rational designing novel efficacious

参考文章(61)
David E. Gerber, Targeted therapies: a new generation of cancer treatments. American Family Physician. ,vol. 77, pp. 311- 319 ,(2008)
Yung Jue Bang, Seock-Ah Im, Keun-Wook Lee, Taeyou Kim, Hwang Phill Kim, Sang Hyun Song, Tai Young Kim, Hyun Soon Jong, Sang Gyun Kim, Noe Kyeong Kim, Kyung Hae Jung, Jung Hyun Park, Jee Hyun Kim, Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells. Anticancer Research. ,vol. 26, pp. 3429- 3438 ,(2006)
H. J. C. Berendsen, J. P. M. Postma, W. F. van Gunsteren, J. Hermans, Interaction Models for Water in Relation to Protein Hydration The Jerusalem Symposia on Quantum Chemistry and Biochemistry. pp. 331- 342 ,(1981) , 10.1007/978-94-015-7658-1_21
Mark M Awad, Alice T Shaw, ALK Inhibitors in Non–Small Cell Lung Cancer: Crizotinib and Beyond Clinical advances in hematology & oncology. ,vol. 12, pp. 429- 439 ,(2014)
Adam Płużański, Aleksandra Piórek, Maciej Krzakowski, Crizotinib in the treatment of non-small-cell lung carcinoma. Wspolczesna Onkologia-Contemporary Oncology. ,vol. 16, pp. 480- 490 ,(2012) , 10.5114/WO.2012.32477
Steven L. Dixon, Alexander M. Smondyrev, Shashidhar N. Rao, PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching Chemical Biology & Drug Design. ,vol. 67, pp. 370- 372 ,(2006) , 10.1111/J.1747-0285.2006.00384.X
Berk Hess, Carsten Kutzner, David van der Spoel, Erik Lindahl, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation Journal of Chemical Theory and Computation. ,vol. 4, pp. 435- 447 ,(2008) , 10.1021/CT700301Q
Masatoshi Kakihana, Tatsuo Ohira, Daniel Chan, Robin B. Webster, Harubumi Kato, Harry A. Drabkin, Robert M. Gemmill, Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition Journal of Thoracic Oncology. ,vol. 4, pp. 1455- 1465 ,(2009) , 10.1097/JTO.0B013E3181BC9419
Márk Sándor, Róbert Kiss, György M. Keserű, Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes. Journal of Chemical Information and Modeling. ,vol. 50, pp. 1165- 1172 ,(2010) , 10.1021/CI1000407